Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

from may sustain organ damage while preserving defense

Aging may sustain damage by while their retain . Insufficient , or damage declining only after following , would reject the mechanism.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionBlood and blood formation

Ageing mechanism

Main connectionAltered intercellular communication

Direction

Lens

Puts the cause outside the part under study, in the wider system and the conditions it sits in.System and environment

Kind of knowledge gap

A result exists, but its evidence is too fragile to rely on.Fragile gap

A double ring marks the main placement where a group contains several values.

Goal
Ограничение отсроченной цены системного восстановления
Competing hypotheses
3
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
10 / 10Few extra conditions
10 / 10Completeness of the answer
6 / 10Novelty of the idea
8 / 10Few new entities
8 / 10Decisive experiment
8 / 10Silver-bullet potential
4 / 10Support from research
Poster: Stem-cell IL-6 sustains organ damage
PosterOpen the sheet full size2026-10-01

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Signalling molecule

    A secreted signalling molecule

    Where this hypothesis actsSecreted by hematopoietic stem cells with during ageing, between infection episodes

    Hypotheses on this target 2
    Interleukin-6Lower level. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 11Neutralisation. Hypotheses on this target 11Supplementation. Hypotheses on this target 0Accelerated excretion. Hypotheses on this target 0
    • Lower level
    • Synthesis suppression1
    • Neutralisation1
    • Supplementation
    • Accelerated excretion

    What is proposed

    Synthesis suppression

    Suppress synthesis and in hematopoietic stem cells

    With whatControlled genetic model

    HowInducible restriction of expression specifically in stem cells after memory formation, while preserving ' protective memory

    Possible result

    Possible reduction in sustained systemic exposure and lung and kidney damage before myeloid cell turnover

    From the recordПосле формирования памяти ограниченное стволовыми клетками выключение синтеза интерлейкина-6 снижает его межэпизодный уровень

  2. Immune response

    An inherited cellular programme that supports rapid destruction of microorganisms

    Where this hypothesis acts of hematopoietic stem cells with , during repeated infection episodes

    Hypotheses on this target 2
    Antimicrobial memoryInhibition. Hypotheses on this target 0Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 22Clearance restoration. Hypotheses on this target 0Immunosuppression. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0
    • Inhibition
    • Activation
    • Function preservation2
    • Clearance restoration
    • Immunosuppression
    • Feedback restoration
    • Rhythm restoration

    What is proposed

    Function preservation

    Preserve the ' protective

    With whatNot stated in the record

    HowRestrict suppression to stem cells while retaining myeloid cell abundance, and early

    Possible result

    Possible preservation of rapid antimicrobial protection while chronic organ damage decreases

    From the recordБыстрая противоинфекционная защита обеспечивается отдельной, наследуемой потомками программой уничтожения микроорганизмов.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistPotassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNTInterleukin-6. Hypotheses on this target 2Interleukin-6
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionAntimicrobial memory. Hypotheses on this target 2Antimicrobial memory
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

A lasting memory of infection might preserve rapid protection while also keeping organs exposed to damaging inflammation. The unexpected move is to assign these effects to different cells: a small population of , which produce new blood cells, would supply the damaging signal, while their would carry protection. This is a proposal generated by the pipeline, not a measured separation of those functions.

The proposed mechanism, link by link
  1. Prior inflammation leaves lasting changes in .
  2. The changed stem cells are proposed to release continuously between infection episodes.
  3. During aging, release from this small population is proposed to become sufficient to sustain damage in several organs.
  4. Stem-cell are proposed to inherit a separate program for rapidly killing microbes.
  5. Stopping production specifically in stem cells is predicted to reduce the continuing signal and organ damage before existing are replaced.
  6. Restoring the measured normal rate of delivery is predicted to bring the damage back.
A picture for it

A workshop keeps producing trained repair crews while its own alarm rings continuously and disrupts the neighborhood. Silencing the workshop's alarm could end the disturbance without removing the crews' skills.

Where the picture breaks: The picture assumes that the alarm and the crews' skills operate independently. That independence, and whether such a small workshop can produce enough disturbance, are precisely what the biological proposal still has to establish.

  1. Master questionstep 01 of 04

    Aging processes may reinforce one another, so changing a shared cause could benefit several body systems at once.

    Rests on: The goal is to find a single intervention with benefits across several processes involved in aging.

    Assumption

    The starting premise assumes that a shared causal link can be targeted to produce benefits across multiple systems. The supplied material does not establish such a target.

  2. Goal pillarstep 02 of 04

    Restoring function across the body should come with fewer harmful consequences later.

    Rests on: The preceding goal seeks benefits across several systems, but does not describe delayed harm caused by restoration.

    Leap

    The chain does not supply the connection between a shared cause of aging and limiting a delayed cost of restoration, or identify the restoration and cost involved.

  3. Gap questionstep 03 of 04

    Lasting changes left by inflammation in might contain separable programs for chronic damage and rapid infection defense. Changing those cellular changes and the surrounding tissue independently before repeated infections could help distinguish their contributions.

    Rests on: The previous stage calls for limiting delayed harm, but does not identify remembered inflammation in as its cause.

    Leap

    The missing connection is why this particular cellular memory and tissue environment account for the delayed cost named in the preceding stage. The supplied sources address related immune memory, but do not establish that connection.

  4. Hypothesisstep 04 of 04

    with lasting changes from inflammation are proposed to release enough to sustain damage across organs during aging. Their would inherit a separate infection-fighting program, allowing the damaging release to be stopped without erasing protection.S5S6S7

    Rests on: The preceding question supplies the distinction between damaging and protective memory. The endpoint adds a proposed cellular division: stem cells provide the continuing damaging signal, and provide rapid defense. JCI Insight (2026, S5) reports that rare changes in , the packaging of genetic material that helps regulate gene activity, persist across stages of blood-cell development after infection. This supports inheritance of some cellular changes, but does not establish the proposed source, organ damage, or preservation of protection after the intervention. Frontiers in Immunology (2025, S6) reviews findings that are required for lasting , a persistent change in the response of the body's early immune defenses. It does not establish direct release by those cells or the proposed separation of damage and protection. Advanced Science (2026, S7) reports improved defense against a later bacterial infection following transfer of a population enriched for early blood-forming cells in mice. It does not establish the proposed mechanism during aging or test selective interruption of stem-cell .

    Assumption

    The proposal assumes that the rare stem-cell population supplies a quantitatively sufficient, continuing signal and that retain protective function independently of that signal. These are the mechanism's stated premises, not established findings.

What is carried, and what is not. Three component links have partial support in the cited material: persistence of immune memory involving stem cells, inheritance of some changes in genetic packaging, and enhanced defense against a later infection. None of those sources establishes the sequence from direct stem-cell release to sustained organ damage, followed by reduced damage with protection preserved when that release stops.

Where the reasoning is carried by something unstated · 4
  • Master question. The starting premise assumes that a shared causal link can be targeted to produce benefits across multiple systems. The supplied material does not establish such a target.
  • Goal pillar. The chain does not supply the connection between a shared cause of aging and limiting a delayed cost of restoration, or identify the restoration and cost involved. Establish the missing link before relying on this step.
  • Gap question. The missing connection is why this particular cellular memory and tissue environment account for the delayed cost named in the preceding stage. The supplied sources address related immune memory, but do not establish that connection. Establish the missing link before relying on this step.
  • Hypothesis. The proposal assumes that the rare stem-cell population supplies a quantitatively sufficient, continuing signal and that retain protective function independently of that signal. These are the mechanism's stated premises, not established findings.
How a result here could mislead · 3
  • Reduced damage could be credited to direct stem-cell release even if the intervention also changes , blood-cell production, or the local tissue that supports stem cells. What closes it: The intervention's restriction to stem cells must be demonstrated. The proposed tracking of must establish that damage changes before their replacement, while their numbers, genetic packaging, and early infection-fighting activity remain comparable with ; changes in blood-cell production and the supporting tissue must be measured separately.
  • A fall in circulating could be mistaken for proof that stem cells directly supplied the damaging amount. It could instead reflect a change in release from other cells, and restoring the signal could restore damage without identifying its original source. What closes it: Measurements of release by individual stem cells must be combined with their abundance to establish whether their total output can account for the proposed exposure. The restoration experiment must reproduce the measured , rather than an arbitrary amount.
  • An absence of reduced damage could be read as rejection of the mechanism even if production was not sufficiently stopped. Conversely, comparable early infection-fighting activity could be read as proof that protection remains intact throughout repeated infections. What closes it: Loss of the targeted release must be verified before interpreting a negative result. Preservation of protection must also be assessed through the repeated infection episodes specified by the question; the supplied material gives no fixed criterion for sufficient suppression or preserved protection, so those criteria must be set before results are interpreted.

What would make this wrong. The central claim would fail if the stem-cell population does not release enough to account for the proposed continuing exposure, or if reduced damage appears only after its are replaced. Verified selective suppression that leaves the continuing signal and organ damage unchanged would also contradict the damaging-source claim; loss of infection defense despite unchanged and supporting tissue would contradict the proposed independence of protection.

What it would change. If the mechanism held, one continuing signal from a small cell population could connect damage in several organs while remaining separable from useful infection memory. Work toward a shared intervention against aging would then need to distinguish the cells supplying chronic harm from the carrying protection, rather than treating all remembered inflammation as one target. Even a successful test would not by itself establish longer life, benefits beyond the measured organs, or applicability to humans; the endpoint does not specify the species or duration of testing.

Sources read · 4

3 literature searches, 10 full texts; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S5Partly answers it

Rare epigenetic alterations are conserved across hematopoietic differentiation stages after mycobacterial infection. · JCI insight · 2026

“Overall, we provide one of the first studies to our knowledge to determine whether chromatin modifications induced in HSPCs are conserved through stages of myeloid differentiation.”

Does not settle: Источник и роль интерлейкина-6, хроническое повреждение органов, системное воздействие при старении, избирательное прекращение секреции в стволовых клетках и сохранение противоинфекционной защиты после такого вмешательства.

S6Partly answers it

Advocating the role of trained immunity in the pathogenesis of ME/CFS: a mini review. · Frontiers in immunology · 2025

“However, more recent findings indicate that hematopoietic stem cells in the bone marrow are required for long-term persistence of trained immunity.”

Does not settle: It does not establish direct IL-6 secretion by hematopoietic stem cells, organ damage caused by such secretion, an aging-associated source contribution, or that selectively stopping stem-cell IL-6 preserves antimicrobial memory in descendants.

S7Partly answers it

BCG HSP70 Reprograms Macrophages via Central Trained Immunity to Suppress Prostate Cancer. · 2026

“Together, these data indicated that pre‐stimulation with Dnak induces persistent functional changes in LSK cells, conferring a significantly improved response against secondary bacterial infection.”

Does not settle: Источник не исследует интерлейкин-6, хроническое повреждение органов, старение или избирательное прекращение секреции в стволовых клетках. Он показывает противоинфекционную защиту после переноса клеток LSK в модели мышей.

S8Partly answers it

Mesenchymal Stromal Cells Facilitate Neutrophil-Trained Immunity by Reprogramming Hematopoietic Stem Cells. · Journal of innate immunity · 2023

“Despite an increased number of neutrophils, infected chimeras transplanted with CpG-BM had lower levels of IL-6 and IL-17A compared to both infected chimeras transplanted with MSC-BM and Ctrl-BM ( i), suggesting that the augmented granulopoiesis was not arising from a persistent, dysregulated cytokine response”

Does not settle: Источник интерлейкина-6, прямой секреторный вклад кроветворных стволовых клеток, хроническое повреждение органов при старении и эффект избирательного прекращения секреции интерлейкина-6 в этих клетках. Работа описывает мышиные костномозговые химеры и ответ на инфекцию P. aeruginosa.

The gap this hypothesis explains

Something is claimed here, but it rests on evidence too thin to carry weight.

Can changing blood-forming stem-cell memory separately from its surroundings reduce lasting damage while preserving protection against repeated infections?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Можно ли причинно разделить на программу хронического повреждения и программу быстрой защиты, если независимо изменять и перед повторными инфекционными эпизодами?

What this question is asking

The question concerns lasting changes in after inflammation, and whether their harmful and protective effects can be separated. It asks what happens when those lasting changes and the surrounding tissue are altered independently before repeated infections. The comparison is whether lasting damage can decrease while the body still limits the amount of infection in the first hours and days and retains that ability across later episodes. It assumes that cell memory and the surrounding tissue could contribute to both outcomes, but the supplied sources do not establish two distinct programs that can be independently controlled.

What the terms mean
Blood-forming stem cells
Cells that can maintain their own population and produce the different types of blood cells, including immune cells. Lasting changes in these cells are the proposed starting point of the question.
Progenitor cells
of stem cells that produce a more restricted range of cell types. S2 discusses them together with , so its statement is not limited to stem cells alone.
Inflammation
A collection of bodily responses to infection or injury. In this question, it is the earlier condition proposed to leave lasting changes in blood-forming cells; inflammation and lasting tissue damage are not interchangeable measurements.
Cell memory or inflammatory memory
A lasting alteration in how a cell responds after an earlier exposure, rather than conscious memory. Here it names a proposed persistent state, not an already identified single mechanism with proven harmful and protective components.
Cellular program
A coordinated pattern of activity within cells. Calling damage and protection separate programs does not establish that they have distinct causes or can be independently switched off.
Tissue surroundings
Nearby cells and the local conditions and signals that influence a cell. For , the supplied sources discuss supporting surroundings within bone marrow.
Bone marrow
Tissue inside bones where blood cells are produced. It contains both blood-forming cells and cells that support and regulate them.
Mesenchymal stromal cells
A class of supporting cells that can release signals affecting other cells. In S7, their released signals are reported to leave prepared for a later enhanced response.
Emergency granulopoiesis
An increased production of granulocytes, a group of immune cells, in response to urgent demand. This is the response described in S7; increased cell production alone does not establish reduced infection or reduced lasting damage.
Chimeric mouse model and transplantation
A research setting in which a mouse contains introduced cells from another source; transplantation is the transfer of those cells. S7 reports a response months after that transfer, which is a different timescale from measuring infection during its first hours and days.
Bacillus Calmette–Guérin vaccination
The vaccination examined in S8 for its capacity to protect against viral disease. The supplied quote describes that protection as dependent on the disease process and tissues involved.
Cellular metabolism and regulation of gene activity
Cellular metabolism comprises the chemical processes through which cells obtain and use materials and energy. Regulation of gene activity how cells use their genetic instructions; S2 reports changes in both processes, without establishing their effects on repeated infections.
Programmed cell death
A regulated process through which a cell is eliminated. S3 discusses its alongside cell division, rather than directly measuring the damage-versus-protection distinction in the question.
Causal separation
Distinguishing what each factor actually produces, rather than merely observing that factors change together. Here the factors are lasting states within and influences from their surroundings.
Chronic damage and protective capacity
Chronic damage means continuing or lasting injury; protective capacity means the ability to limit infection, including during later episodes. They are outcomes requiring defined measurements, and the supplied material provides no numerical boundaries for either.
What the question takes for granted
Premise only partly supported
in and signals from their tissue surroundings contribute to chronic damage and rapid protection as potentially separable programs.

produce blood and immune cells, while nearby supporting cells supply signals that influence their behavior. The assumption is that lasting changes within the stem cells and signals from those surroundings help determine both continuing injury and rapid defense against infection. If that holds, separating their contributions could explain whether reducing injury also removes protection.

S7 supports a narrower claim: signals released by supporting cells can leave prepared for an enhanced response months after transplantation in mice. S2 reports changes in both blood-forming cells and supporting cells in diabetes, and S3 describes regulation by mechanisms inside stem cells together with signals from their surroundings. These findings do not establish that causes both chronic damage and rapid protection, that these are distinct programs, or that their contributions have been independently separated before repeated infections.S2S3S7

The same question asked without the part nothing read establishes:

  • Does independently changing lasting states in and their surroundings affect chronic damage differently from early protection across repeated infections?
  • What do lasting changes within and signals from their surroundings each contribute to damage and protection during repeated infections?
What turns on the answer
  • Damage falls and protection remains Under the question's proposed mechanism, a change would reduce the contribution to lasting injury while preserving early of infection across later episodes. This would support functional separation under the conditions examined, although it would not by itself establish two distinct internal programs.
  • Damage and protection fall together The change would reduce lasting injury but also weaken early of infection or the ability to respond to later episodes. The apparent benefit from reduced damage would therefore come with a loss of defense; this outcome alone would not prove that a single internal program causes both effects.
  • The outcome depends on the surroundings The same lasting cell state would produce different outcomes in different tissue surroundings. Protection or damage could then not be attributed to cell memory alone, and an effect observed in one setting would not establish the same tradeoff in another.
Why it matters

In the mechanism proposed by the question, an earlier inflammatory episode changes , which can then change the supply or behavior of cells involved in later defenses. Signals from surrounding tissue could also influence these responses, making it difficult to attribute an outcome to memory inside the cells alone. If the same lasting change supports both damage and protection, removing it could reduce damage while weakening early of infection. If those effects are separable, reducing damage would not necessarily require losing protection, but that separation is not demonstrated in the supplied evidence.

What is already established

Узлы RL-1 описывают память и ; измерения RL-2 отслеживают состояния, но разделимость повреждения и защиты экспериментально не установлена.

What would have to be true

После снижения воспаления ограничивается в первые часы и сутки; повторные эпизоды сохраняют в заданных границах.

What is missing

Неизвестно, устраняет ли изменение памяти общий источник повреждения или одновременно расходует необходимый ; причинность и окружения остаётся неразделённой.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Хроническое повреждение поддерживается прямой -6 с . Предполагается, что при старении их небольшой становится существенным источником длительного . Быстрая обеспечивается отдельной, наследуемой программой уничтожения микроорганизмов. Поэтому избирательное прекращение -6 в должно уменьшить повреждение нескольких органов при сохранении защитной памяти их . Это разделение источника хронического воздействия и носителей быстрой защиты делает полное стирание памяти избыточным.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

После формирования памяти ограниченное выключение -6 снижает его и последующее повреждение лёгких и почек раньше обновления . Численность, и ранняя этих клеток остаются сопоставимыми с . Восстановление измеренного -6 возвращает повреждение. Отсутствие достаточного потока из или появление эффекта только после опровергает центральное утверждение.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies directional changes, timing relative to cell turnover, control comparisons, restoration of damage, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Возможны в , и . Главная трудность состоит в доказательстве и количественной достаточности редкого . Эксперимент должен отдельно контролировать изменения и образования клеток крови.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

После формирования памяти ограниченное выключение -6 снижает его и последующее повреждение лёгких и почек раньше обновления . Численность, и ранняя этих клеток остаются сопоставимыми с . Восстановление измеренного -6 возвращает повреждение. Отсутствие достаточного потока из или появление эффекта только после опровергает центральное утверждение.

  • What would separate them

    Molecular crowding may shift enzyme forms to preserve rapid antimicrobial defense predicts: При одинаковых количестве , составе клеток и обратимое изменение доли объёма, занятого , меняет образование и раннее уничтожение микроорганизмов. Эффект возникает до изменения . В воспроизводятся направление и величина сдвига . Если влияние исчезает после , кислотности и либо сопровождается только изменением , теряет поддержку.

  • What would separate them

    Queuosine modification may separate antimicrobial protection from inflammatory damage predicts: При одинаковом количестве изменение меняет отношение выбранных защитных и повреждающих белков. Зависимость защитного белка от модификации исчезает после чувствительных при сохранении его и сопоставимых количества и . Такая замена восстанавливает раннюю защитную функцию после ослабления . Сохранение эффекта после замены либо отсутствие различий между защитным и повреждающим наборами белков опровергает предложенное разделение.

  • What would separate them

    Carbamylation may turn protective cathelicidins into tissue-damaging molecules predicts: При одинаковой и одинаковой ранней повреждение ткани определяется долей конкретных . Химически определённая человеческого повышает повреждение при сохранении в подходящей . Ограничение образования этой формы уменьшает повреждение, а её добавление в измеренной возвращает его. Отсутствие достаточного количества модифицированного или эффекта его избирательной замены опровергает механизм.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

Zhao и соавторы показали интенсивную различных и . Неожиданная секреторная активность служит основанием для гипотезы, однако её перенос на долгоживущие клетки старого организма требует проверки. [Первичное исследование](https://pubmed.ncbi.nlm.nih.gov/24561084/).

Subfield revised

Биология . Пересмотру подлежал бы учебный раздел «Передача памяти через »: для потребовалось бы признать ведущую прямую самих .

Testable surprise

Выключение одного секретируемого продукта исключительно в редких быстро прекращает повреждение удалённых органов, хотя и функциональная активность уже существующих сохраняются.

Why this is not the mainstream account

Адресный поиск выявил известную , но не установил существование обзора, утверждающего количественно ведущую прямую в повреждении стареющих органов. Это ограниченная проверка новизны, а не доказательство отсутствия публикаций; статус HERETICAL предварительный.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.